447 third-party lab reports published 3 for the price of 2 on compound vials and capsules — put any 3 in your cart and the cheapest one is free, automatically. Solvents and lab supplies excluded. Ends Tuesday night. For research use only. 99.58% median purity across 253 lots Defense, VA, Federal and Public safety: your VerifyPass code adds 5% on top of 3 for the price of 2 · get verified 241 / 241 lots pass sterility

‹ Certificates CJC No DAC IPA Blend Lot 1684

Lab report (Certificate of Analysis, COA)

CJC No DAC IPA Blend · 5mg each (10mg total)

Batch 1684 · tested June 1, 2026 (113 days ago) · released July 15, 2026

All tests passed

Batch
#1684 14 tests
Mass
5mg each (10mg total)
Purity
99.30%
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01

3 units tested for purity: 99.30 / 99.31 / 99.30% · spread 0.01 pt · net peptide content · ipamorelin 5.23 / 5.13 / 5.26 mg · net peptide content · cjc-1295 5.03 / 4.96 / 5.00 mg

Conformity: Units agree — every reported unit passed on all 11 test rows · purity spread 0.01 pt within the house limit · content spread (Ipamorelin) 2.5% within the house limit · content spread (CJC-1295) 1.4% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-06-01

Vanguard · issuing labEagle Analytical · sterility

Verified by Vanguard Laboratory

This certificate is also hosted by Vanguard Laboratory — the issuing lab — on its own verification site.

View on VerifiedByVanguard.com
Laboratory ID V260515-17 001

Notes

Content audit 9 Sep 2026: product #564 CJC-1295 No DAC → #548 CJC No DAC IPA Blend; size 24495 → #686 5mg-each-10mg-total. Certificate prints: prints compound "CJC-1295 no DAC/Ipamorelin", lot "1684", lab id "V260515-17 001", content Ipamorelin: 5.23 / 5.13 / 5.26 mg; CJC-1

Reports for this lot

  1. Vanguard Laboratory this report · tested June 1, 2026 · 11 results · QA approvalVanguard · issuing labEagle Analytical · sterilityAll tests passed

Test by test

11 results on the report · 4 rows computed from the per-unit values · 2 labs · each test used up to 5 vials from this lot (rows are not added together) · every row names the chapter or house rule it follows

PurityWithin limits
avg 99.30% · 3 units · USP <621> (procedural chapter)
Purity consistency between unitsWithin house limit
3 units: 99.30 / 99.31 / 99.30% · spread 0.01 pt · house limit · caution past 0.50 pt, outside past 1.00 pt · per-unit USP <621> results
Net peptide content (assay) · IpamorelinWithin limits
avg 5.21 mg · 3 units · USP <621> (procedural chapter)
Net peptide content (assay) · CJC-1295Within limits
avg 5.00 mg · 3 units · USP <621> (procedural chapter)
Content consistency between units · IpamorelinWithin house limit
3 units: 5.23 / 5.13 / 5.26 mg · spread 0.13 mg, 2.5% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
Content consistency between units · CJC-1295Within house limit
3 units: 5.03 / 4.96 / 5.00 mg · spread 0.07 mg, 1.4% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
Heavy metalsWithin limits
5 elements non-detect · 2 units · dose-scaled limits derived from USP <232> (limits chapter)

Residual solventsWithin limits
all non-detect · 1 unit · USP <467> (procedural chapter)
Trifluoroacetic acidWithin limits
all non-detect · 1 unit · house limit · ion chromatography, the lab's method; no compendial chapter for the method run · limit <0.10% (the lab's)
EndotoxinsPass
3 of 3 pass · 3 units · USP <85> (procedural chapter) · limit <5.00 EU/mg (the lab's)
Container closurePass
3 of 3 pass · 3 units · USP <1207> (informational chapter (1000-series))
SolubilityPass
3 of 3 pass · 3 units · house check · no compendial chapter
SterilityPass
5 of 5 pass · 5 units · USP <71> (procedural chapter)
SterilityPass
1 of 1 pass · 1 unit · USP <71> (reference) · a rapid viability test used as an alternative to the USP <71> growth test; USP <1223> is the validation framework (informational chapter) · at Eagle Analytical
ConformityUnits agree
every reported unit passed on all 11 test rows · purity spread 0.01 pt within the house limit · content spread (Ipamorelin) 2.5% within the house limit · content spread (CJC-1295) 1.4% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-06-01 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Tested by Vanguard Laboratory · Eagle Analytical Services Inc. · Released July 15, 2026 · Verify: go.peptidology.co/H2QMPD

Permanent URL: https://peptidology.co/coa/cjc-1295-no-dac-lot-1684/

For research use only. Not intended for diagnostic or therapeutic use.

This certificate has been viewed 5 times.